Can a new pill tame Menopause's worst symptoms? 1,500 women to test it in daily life

NCT ID NCT07490431

Not yet recruiting Symptom relief Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how well a new, non-hormonal medication called elinzanetant works for managing hot flashes, night sweats, and sleep problems in real-world settings. Researchers will follow about 1,500 women in the U.S. who are starting this treatment as part of their usual medical care. The study will collect information through surveys and some wearable devices to see how the treatment affects women's symptoms, sleep, and daily life over 12 weeks to 2 years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASOMOTOR SYMPTOMS (VMS) ASSOCIATED WITH MENOPAUSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bayer

    Whippany, New Jersey, 07981, United States

Conditions

Explore the condition pages connected to this study.